Novartis Again Beats MSN Push to Launch Entresto Copy Early (1)

MSN Laboratories Pvt. Ltd. lost its bid to force Novartis AG to remove a key patent for Entresto from the FDA’s Orange Book, as a federal judge refused to undo his judgment blocking MSN’s copies of the blockbuster heart-disease drug until mid-July.

Judge Richard G. Andrews, at a hearing Tuesday in the US District Court for the District of Delaware, granted Novartis’ motion to dismiss MSN’s delisting counterclaim in Novartis’ January 2025 lawsuit and denied MSN’s attempt to vacate or amend his final judgment from earlier Hatch-Waxman litigation.

MSN “not raising the delisting argument through five years of litigation until ...